Connect your AI

SIGA Technologies SIGA Deferred Revenue

Deferred Revenue at other companies

Stoke Therapeutics, Inc.STOK

——

Other financials

Income statement

Revenue$6.2M-11.3%

Gross profit$3.3M-52.0%

Operating income-$5.3M-136%

Net income-$3.5M-746%

EPS (diluted)-$0.05-400%

Balance sheet

Cash & equivalents$145.6M-10.3%

Total debt$601.0K-50.6%

Total equity$151.6M-29.8%

Total assets$219.4M-11.2%

Cash flow

Operating cash flow-$8.7M-223%

CapEx--100%

Free cash flow-$8.7M-223%

Valuation

Market cap$261.08M-44.3%

Enterprise value$116.11M-59.6%

P/E10.3×+3.8×

P/S2.8×+0.2×

Profitability

Gross margin65.4%-11.2pp

Operating margin52.4%-7.8pp

Net margin43.2%-6.1pp

FCF margin66.2%—

Returns & leverage

Return on equity39.9%-18.5pp

Debt / equity0×0.0×

Current ratio3.2×-5.2×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SIGA Technologies's deferred revenue?: SIGA Technologies (SIGA) reported deferred revenue of -$1.36M in Q1 2026.